GliadinDP IgG antibody detection reagent - Taiwan Registration bc02df78aeb2e79de10d670bf6bb310c
Access comprehensive regulatory information for GliadinDP IgG antibody detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number bc02df78aeb2e79de10d670bf6bb310c and manufactured by PHADIA AB;; PHADIA GMBH. The authorized representative in Taiwan is PHADIA TAIWAN INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
bc02df78aeb2e79de10d670bf6bb310c
DHA05603309408
Product Details
This product is used for the in vitro quantitative determination of IgG antibodies to gliadin in human serum and plasma to assist in the clinical diagnosis of celiac disease. This product is tested using the IgG method in the Fadia 100 and Fadia 250 instruments. Performance changes (new applicable models): See Chinese copy of the copy.
C Immunology and microbiology
C.5660 ๅค็ผๆง่ช้ซๆ้ซๅ ็ซ่ฉฆ้ฉ็ณป็ตฑ
import
Dates and Status
Dec 02, 2019
Dec 02, 2029